Shahneen K Sandhu
Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancer
de Bono J, Scranton J, Wang T, Hudes G, Gillessen Sommer S, Fong P, Sandhu S, Aparicio L, Saad F, Petrylak D, Pandha H, Piulats J, Pollak M. Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancer. Clin Cancer Res 2014; 20:1925-34.
Feb 17, 2014Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancer
Feb 17, 2014Clin Cancer Res 2014; 20:1925-34
de Bono Johann S, Scranton Judith, Wang Tao, Hudes Gary R, Gillessen Sommer Silke, Fong Peter, Sandhu Shahneen K, Aparicio Luis Miguel A, Saad Fred, Petrylak Daniel P, Pandha Hardev S, Piulats Josep M, Pollak Michael N
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial
Sandhu S, Gevensleben H, Sun L, Loughney J, Chatterjee M, Toniatti C, Carpenter C, Iannone R, Kaye S, de Bono J, Thway K, Kreischer N, Schelman W, Wilding G, Moreno V, Baird R, Miranda S, Hylands L, Riisnaes R, Forster M, Omlin A, Wenham R. The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial. Lancet Oncol 2013; 14:882-92.
Jun 28, 2013The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial
Jun 28, 2013Lancet Oncol 2013; 14:882-92
Sandhu Shahneen K, Gevensleben Heidrun, Sun Linda, Loughney John, Chatterjee Manash, Toniatti Carlo, Carpenter Christopher L, Iannone Robert, Kaye Stan B, de Bono Johann S, Thway Khin, Kreischer Nathan, Schelman William R, Wilding George, Moreno Victor, Baird Richard D, Miranda Susana, Hylands Lucy, Riisnaes Ruth, Forster Martin, Omlin Aurelius, Wenham Robert M